ES2434416T3 - Preparación oral con liberación controlada - Google Patents

Preparación oral con liberación controlada Download PDF

Info

Publication number
ES2434416T3
ES2434416T3 ES05774025T ES05774025T ES2434416T3 ES 2434416 T3 ES2434416 T3 ES 2434416T3 ES 05774025 T ES05774025 T ES 05774025T ES 05774025 T ES05774025 T ES 05774025T ES 2434416 T3 ES2434416 T3 ES 2434416T3
Authority
ES
Spain
Prior art keywords
active ingredient
pellets
core
pellet
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES05774025T
Other languages
English (en)
Spanish (es)
Inventor
Burkhard Schlütermann
Manfred Kohlmeyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADD Advanced Drug Delivery Technologies AG
Original Assignee
ADD Advanced Drug Delivery Technologies AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35610043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2434416(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ADD Advanced Drug Delivery Technologies AG filed Critical ADD Advanced Drug Delivery Technologies AG
Application granted granted Critical
Publication of ES2434416T3 publication Critical patent/ES2434416T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES05774025T 2005-08-10 2005-08-10 Preparación oral con liberación controlada Active ES2434416T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/008700 WO2007016948A1 (de) 2005-08-10 2005-08-10 Orales präparat mit kontrollierter freisetzung

Publications (1)

Publication Number Publication Date
ES2434416T3 true ES2434416T3 (es) 2013-12-16

Family

ID=35610043

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05774025T Active ES2434416T3 (es) 2005-08-10 2005-08-10 Preparación oral con liberación controlada

Country Status (7)

Country Link
US (2) US11311490B2 (de)
EP (1) EP1915137B8 (de)
DK (1) DK1915137T3 (de)
ES (1) ES2434416T3 (de)
PL (1) PL1915137T3 (de)
SI (1) SI1915137T1 (de)
WO (1) WO2007016948A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008048729A1 (de) * 2008-09-24 2010-03-25 Add Technologies Ltd Advanced Drug Delivery Multipartikuläre Tabletten und Verfahren zur deren Herstellung

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237575A1 (de) 1982-10-09 1984-04-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale mopidamolformen
SE450087B (sv) 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
US4810501A (en) 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
CA2007181C (en) 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
IE912955A1 (en) 1990-08-24 1992-02-26 Spirig Ag Process for the production of pellets
US5376384A (en) 1992-12-23 1994-12-27 Kinaform Technology, Inc. Delayed, sustained-release pharmaceutical preparation
DE4313726A1 (de) 1993-04-27 1994-11-03 Byk Nederland Bv Feste Darreichungsform
CA2192086C (en) 1994-06-15 2000-01-25 Tomas Norling Pellets
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5508276A (en) 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5718919A (en) 1995-02-24 1998-02-17 Nanosystems L.L.C. Nanoparticles containing the R(-)enantiomer of ibuprofen
DE19630035A1 (de) 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
AR019935A1 (es) 1998-07-28 2002-03-27 Takeda Pharmaceutical Preparacion solida de desintegracion rapida, uso de una hidroxipropil celulosa poco sustituida en dicha preparacion y metodo para mejorar la capacidad dedesintegracion rapida de la misma
AU764469B2 (en) 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
US6475493B1 (en) * 1999-09-02 2002-11-05 Norstrum Pharmaceuticals, Inc. Controlled release pellet formulation
GB0018968D0 (en) 2000-08-02 2000-09-20 Pfizer Ltd Particulate composition
EP1252886A1 (de) 2001-04-27 2002-10-30 Universiteit Gent Pharmazeutische Pelletformulierungen für eine kontrollierte Freisetzung
US6620439B1 (en) * 2000-10-03 2003-09-16 Atul M. Mehta Chrono delivery formulations and method of use thereof
SE0100824D0 (sv) 2001-03-09 2001-03-09 Astrazeneca Ab Method III to obtain microparticles
US20050112115A1 (en) * 2001-05-29 2005-05-26 Khan Mansoor A. Surface roughness quantification of pharmaceuticals, herbal, nutritional dosage forms and cosmetic preparations
US6552172B2 (en) 2001-08-30 2003-04-22 Habto Biotech, Inc. Fibrin nanoparticles and uses thereof
US6500454B1 (en) 2001-10-04 2002-12-31 Eurand Pharmaceuticals Ltd. Timed, sustained release systems for propranolol
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
CA2531136A1 (en) 2003-07-04 2005-01-13 Nycomed Danmark Aps Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
DE102004028975A1 (de) * 2004-06-16 2006-01-05 Add Advanced Drug Delivery Technologies Ltd. Orales Präparat mit kontrollierter Freisetzung

Also Published As

Publication number Publication date
US11311490B2 (en) 2022-04-26
PL1915137T3 (pl) 2014-03-31
EP1915137B1 (de) 2013-08-07
SI1915137T1 (sl) 2013-12-31
US20110274819A1 (en) 2011-11-10
WO2007016948A1 (de) 2007-02-15
EP1915137A1 (de) 2008-04-30
US20100151017A1 (en) 2010-06-17
EP1915137B8 (de) 2013-09-11
DK1915137T3 (da) 2013-11-04

Similar Documents

Publication Publication Date Title
JP5366549B2 (ja) 即時放出特性及び／又は制御放出特性を有する薬学的剤形
EP2477608B1 (de) Feste orale dosierungsform mit nanopartikeln und verfahren zu ihrer formulierung mithilfe von fischgelatine
RU2563993C1 (ru) Способы лечения нарушений желудочно-кишечного тракта независимо от потребления пищи
JP5636364B2 (ja) 徐放性骨格筋弛緩薬剤形の調製
JP2009532331A (ja) 鎮静剤および睡眠剤の経口放出制御製剤
EP2910243A1 (de) Herstellung einer osmotischen pharmazeutischen pumpe
US20200108008A1 (en) Olaparib oral sustained and controlled release pharmaceutical composition and uses thereof
KR20210147082A (ko) 디메틸푸마레이트를 포함하는 일일 저용량 투여용 약제학적 조성물
TW201605446A (zh) 普多比啶（ｐｒｉｄｏｐｉｄｉｎｅ）之修飾釋放調配物
CN102238946B (zh) 用于哌醋甲酯的控制释放的药物组合物
US11291660B2 (en) Method of treating heart failure with preserved ejection fraction by administering milrinone
US20120082721A1 (en) Enteric coating
ES2643497T3 (es) Formulaciones estabilizadas de compuestos del SNC
ES2347355T3 (es) Preparado oral con liberacion controlada.
US20150164920A1 (en) Controlled release formulation comprising mesalamine
US9439865B2 (en) Coating film, and granules and tablets each utilizing same
US20240024311A1 (en) A controlled release pharmaceutical composition of selexipag or it's active metabolite
ES2434416T3 (es) Preparación oral con liberación controlada
Ma et al. Production and in vitro evaluation of a lamotrigine extended release tablet based on a controlled-porosity osmotic pump system
Patel et al. Multiple unit pellet system (mups) based fast disintegrating delayed-release tablets for pantoprazole delivery
CN108096251B (zh) 一种吉非替尼药物组合物及其制备方法
Kercˇ Threeform—Technology for Controlled Release of Amorphous Active Ingredient for Once-Daily Administration